Autor: "Kruis, Wolfgang" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Novel Budesonide Suppository and Standard Budesonide Rectal Foam Induce High Rates of Clinical Remission and Mucosal Healing in Active Ulcerative Proctitis: a Randomised, Controlled, Non-inferiority Trial.
Autorzy:: Kruis W; Emeritus Head of Gastroenterology, Ev. Krankenhaus Kalk, University of Cologne, Germany.
Siegmund B; Department for Gastroenterology, Infectious diseases and Rheumatology, Campus Benjamin Franklin, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Lesniakowski K; Department VII of Gastroenterology, Hepatologie and Clinical Nutrition, Wojewódzki Szpital Specjalistyczny im. J. Gromkowskiego, Wroclaw, Poland.
Simanenkov V; State Budgetary Healthcare Institution 'City Hospital #26', Saint-Petersburg, Russian Federation.
Khimion L; Municipal Institution of Kyiv Regional Rada 'Kyiv Regional Clinical Hospital', Kyiv, Ukraine.
Sobon M; Centrum Medyczne Pratia Bydgoszcz, Bydgoszcz, Poland.
Delmans G; Endoscopy Department, Daugavpils Regional Hospital, Daugavpils, Latvia.
Maksyashina SV; State Public Health Institution 'Novgorod regional clinical hospital', Velikiy Novgorod, Russian Federation.
Sablin OA; Federal State Budget Public Health Institution All-Russian centre of Emergency and Radiation medicine n. a., A.M.Nikiforov of Ministry of Emergency Situations of Russia, Saint-Petersburg, Russian Federation.
Pokrotnieks J; Pauls Stradins Clinical University Hospital, Gastroenterology, Hepatology and Nutrition Centre, Riga, Latvia.
Mostovoy Y; Private small-scale enterprise 'Pulse', Therapeutical Department, Vinnitsya, Ukraine.
Datsenko O; Municipal Institution of Healthcare 'Prof. Shalimova Kharkiv City Clinical Hospital # 2', Kharkiv, Ukraine.
Abdulkhakov S; Federal State Budget Educational Institution of High Education 'Kazan State Medical University', Kazan, Russian Federation.; Federal State Autonomous Educational Institution of High Education 'Kazan [Volga region] Federal University', Kazan, Russian Federation.
Dorofeyev A; Ukrainian-German Gastroenterology Center 'BYK-Kyiv', Kyiv, Ukraine.
Levchenko O; Municipal Institution 'Odesa Regional Clinical Hospital', Polyclinic department, Odesa, Ukraine.
Alexeeva O; State Public Health Institution 'Nizhny Novgorod regional clinical hospital n.a. N.A.Semashko', Nizhny Novgorod, Russian Federation.
Andreev P; Non-state Public Health Institution 'Railway clinical hospital on station Samara' of JSC 'Russian railways', Samara, Russian Federation.
Kolesnik IP; Municipal Institution 'Zaporizhzhya City Clinical Hospital of Urgent Care', Surgery department #3, Zaporizhya, Ukraine.
Mihaly E; Semmelweis Egyetem ÁOK, II. Belgyógyászati Klinika, Budapest, Hungary.
Abrahamovych O; Lviv Regional Clinical Hospital, Gastroenterology department; Danylo Halytsky Lviv National Medical University, Lviv, Ukraine.
Baluta M; Centrum Medyczne Pratia Gdynia, Gdynia, Poland.
Kharchenko N; Kyiv City Clinical Hospital #8, Department of Gastroenterology. P.L. Shupyk National Medical Academy of Postgraduate Education, Kyiv, Ukraine.
Viacheslav N; Municipal Institution 'City Hospital #1', Surgery department, Zaporizhya, Ukraine.
Uspenskiy Y; Saint-Petersburg State Public Health Institution 'City Hospital of Saint Venerable Martyr Elizabeth', Saint-Petersburg, Russian Federation.
Vieth M; Friedrich-Alexander-University Erlangen-Nuremberg, Klinikum Bayreuth, Institute of Pathology, Bayreuth, Germany.
Mohrbacher R; Dr. Falk Pharma GmbH, Clinical Research and Development, Freiburg, Germany.
Mueller R; Dr. Falk Pharma GmbH, Clinical Research and Development, Freiburg, Germany.
Greinwald R; Dr. Falk Pharma GmbH, Clinical Research and Development, Freiburg, Germany.; Pokaż więcej
Źródło:: Journal of Crohn's & colitis [J Crohns Colitis] 2022 Nov 23; Vol. 16 (11), pp. 1714-1724.
Typ publikacji:: Randomized Controlled Trial; Journal Article
MeSH Terms:: Colitis, Ulcerative*/drug therapy
Colitis, Ulcerative*/chemically induced
Proctitis*/drug therapy
Proctitis*/etiology
Humans ; Budesonide ; Quality of Life ; Treatment Outcome ; Mesalamine/therapeutic use ; Double-Blind Method ; Remission Induction

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Perianal Fistula-Associated Carcinoma in Crohn's Disease: A Multicentre Retrospective Case Control Study.
Autorzy:: Palmieri C; Department of Internal Medicine and Gastroenterology, Evangelisches Krankenhaus Kalk, University of Cologne, Buchforststrasse, Cologne, Germany.
Müller G; Department of General and Visceral Surgery, Evangelisches Krankenhaus Kalk, University of Cologne, Buchforststrasse, Cologne, Germany.
Kroesen AJ; Department of General and Visceral Surgery, Krankenhaus Porz am Rhein, University of Cologne, Urbacher Weg, Cologne, Germany.
Galata C; Department of Surgery, University of Mannheim, Medical Faculty Mannheim, Heidelberg University, Theodor-Kutzer-Ufer, Mannheim, Germany.
Rink AD; Department of General, Abdominal and Transplantation Surgery, University Medical Center of the Johannes Gutenberg University, Langenbeckstraße, Mainz, Klinikum Leverkusen, Germany.
Morgenstern J; Department of Internal Medicine and Gastroenterology, Evangelisches Krankenhaus Kalk, University of Cologne, Buchforststrasse, Cologne, Germany.
Kruis W; Department of Internal Medicine and Gastroenterology, Evangelisches Krankenhaus Kalk, University of Cologne, Buchforststrasse, Cologne, Germany.; Pokaż więcej
Źródło:: Journal of Crohn's & colitis [J Crohns Colitis] 2021 Oct 07; Vol. 15 (10), pp. 1686-1693.
Typ publikacji:: Journal Article; Multicenter Study
MeSH Terms:: Adenocarcinoma/*complications
Carcinoma, Squamous Cell/*complications
Crohn Disease/*complications
Rectal Fistula/*complications
Rectal Neoplasms/*complications
Adenocarcinoma/mortality ; Adult ; Carcinoma, Squamous Cell/mortality ; Case-Control Studies ; Female ; Germany/epidemiology ; Humans ; Male ; Rectal Neoplasms/mortality ; Retrospective Studies ; Young Adult

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Novel Leucocyte/Thrombocyte Apheresis for Induction of Steroid-Free Remission in Ulcerative Colitis: A Controlled Randomized Pilot Study.
Autorzy:: Kruis W; Evangelisches Krankenhaus Kalk, University of Cologne, Germany.
Nguyen P; Evangelisches Krankenhaus Kalk, University of Cologne, Germany.
Morgenstern J; Evangelisches Krankenhaus Kalk, University of Cologne, Germany.
Ramlow W; Apheresis Center Rostock (ACR), Rostock, Germany.
Dignaß A; Department of Medicine I, Agaplesion Markus Hospital and Crohn Colitis Clinical Research Center Rhein-Main, Frankfurt/Main, Germany.
Stallmach A; Department of Internal Medicine IV (Gastroenterology, Hepatology, Infectious Diseases), University Hospital of Jena, Jena, Germany.
Drebber U; Department of Pathology, University of Cologne, Germany.; Pokaż więcej
Źródło:: Journal of Crohn's & colitis [J Crohns Colitis] 2019 Jul 25; Vol. 13 (7), pp. 949-953.
Typ publikacji:: Journal Article; Multicenter Study; Randomized Controlled Trial
MeSH Terms:: Blood Platelets*
Colitis, Ulcerative/*therapy
Glucocorticoids/*administration & dosage
Leukapheresis/*methods
Prednisolone/*administration & dosage
Adult ; Female ; Germany ; Humans ; Male ; Pilot Projects ; Prospective Studies ; Remission Induction

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Azathioprine-induced Acute Pancreatitis in Patients with Inflammatory Bowel Diseases--A Prospective Study on Incidence and Severity.
Autorzy:: Teich N; Internistische Gemeinschaftspraxis Leipzig Germany .
Mohl W; Gemeinschaftspraxis - Endoskopiezentrum Saarbrücken Germany.
Bokemeyer B; Gastroenterologische Schwerpunktpraxis Minden Germany.
Bündgens B; Praxis Eschweiler Germany.
Büning J; Universitätsklinikum Schleswig-Holstein Lübeck Germany.
Miehlke S; Magen-Darm-Zentrum, Internistische Kooperation Eppendorf Hamburg Germany.
Hüppe D; Gastroenterologische Gemeinschaftspraxis Herne Germany.
Maaser C; Städtisches Klinikum, Lüneburg, Germany.
Klugmann T; Internistische Gemeinschaftspraxis Leipzig Germany.
Kruis W; Evangelisches Krankenhaus Kalk Köln Germany.
Siegmund B; Charité, Berlin, Germany.
Helwig U; Internistische Praxengemeinschaft Oldenburg Germany.
Weismüller J; Gastroenterologische Gemeinschaftspraxis Koblenz Germany.
Drabik A; Universität Münster Germany.
Stallmach A; Universitätsklinikum, Jena, Germany.; Pokaż więcej
Corporate Authors:: German IBD Study Group
Źródło:: Journal of Crohn's & colitis [J Crohns Colitis] 2016 Jan; Vol. 10 (1), pp. 61-8. Date of Electronic Publication: 2015 Oct 13.
Typ publikacji:: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms:: Azathioprine/*adverse effects
Colitis, Ulcerative/*drug therapy
Crohn Disease/*drug therapy
Pancreatitis/*chemically induced
Pancreatitis/*epidemiology
Acute Disease ; Adult ; Age Distribution ; Aged ; Analysis of Variance ; Azathioprine/administration & dosage ; Colitis, Ulcerative/pathology ; Crohn Disease/pathology ; Female ; Germany ; Humans ; Incidence ; Inflammatory Bowel Diseases/drug therapy ; Inflammatory Bowel Diseases/pathology ; Logistic Models ; Male ; Middle Aged ; Multivariate Analysis ; Pancreatic Function Tests ; Pancreatitis/physiopathology ; Prognosis ; Prospective Studies ; Registries ; Risk Assessment ; Severity of Illness Index ; Sex Distribution

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Cerebrovascular events in inflammatory bowel disease patients treated with anti-tumour necrosis factor alpha agents.
Autorzy:: Karmiris K; Department of Gastroenterology, Venizeleio General Hospital, Heraklion, Crete, Greece .
Bossuyt P; Imelda GI Clinical Research Center, Bonheiden, Belgium.
Sorrentino D; IBD Center, Virginia Tech-Carilion School of Medicine, Roanoke, VA, USA and Department of Clinical and Experimental Medical Sciences, University of Udine School of Medicine, Udine, Italy.
Moreels T; Department of Hepato-gastroenterology, Cliniques Universitaires Saint-Luc, Brussels, Belgium.
Scarcelli A; Department of Gastroenterology, Azienda University Hospital, Policlinico di Modena, Italy.
Legido J; Gastroenterology Unit, Segovia General Hospital, Segovia, Spain.
Dotan I; IBD Center, Department of Gastroenterology and Liver Diseases and the Sackler School of Medicine, Sourasky Medical Center, Tel Aviv, Israel.
Naismith GD; Department of Gastroenterology, Paisley RAH, Glasgow, Scotland.
Jussila A; Department of Gastroenterology and Alimentary Tract Surgery, Tampere University Hospital, Tampere, Finland.
Preiss JC; Charité-Universitätsmedizin, Berlin, Germany.
Kruis W; Charité-Universitätsmedizin, Berlin, Germany.
Li AC; Department of Gastroenterology, Western Sussex Hospitals NHSFT, Worthing, UK.
Bouguen G; Department of Gastroenterology, University Hospital Pontchaillou, Rennes, France.
Yanai H; Gastroenterology Unit, Segovia General Hospital, Segovia, Spain.
Steinwurz F; IBD Unit, Hospital Israelita Albert Einstein, Sao Paulo, Brazil.
Katsanos KH; Division of Gastroenterology, University Hospital of Ioannina, Greece.
Subramaniam K; Gastroenterology and Hepatology Unit, Canberra Hospital, Canberra, Australia.
Tarabar D; Department of Gastroenterology, MMA Belgrade, Serbia.
Zaganas IV; Department of Neurology, University Hospital of Heraklion, Heraklion, Crete, Greece.
Ben-Horin S; Department of Gastroenterology, Sheba Medical Center, Tel-Aviv University, Tel-Aviv, Israel.; Pokaż więcej
Corporate Authors:: ECCO CONFER investigators
Źródło:: Journal of Crohn's & colitis [J Crohns Colitis] 2015 May; Vol. 9 (5), pp. 382-9. Date of Electronic Publication: 2015 Mar 04.
Typ publikacji:: Journal Article; Observational Study
MeSH Terms:: Anti-Inflammatory Agents, Non-Steroidal/*therapeutic use
Cerebrovascular Disorders/*etiology
Colitis, Ulcerative/*drug therapy
Crohn Disease/*drug therapy
Immunosuppressive Agents/*therapeutic use
Rare Diseases/*etiology
Tumor Necrosis Factor-alpha/*antagonists & inhibitors
Adalimumab/therapeutic use ; Adult ; Azathioprine/therapeutic use ; Cerebrovascular Disorders/diagnosis ; Certolizumab Pegol/therapeutic use ; Colitis, Ulcerative/complications ; Crohn Disease/complications ; Drug Therapy, Combination ; Female ; Humans ; Infliximab/therapeutic use ; Male ; Methotrexate/therapeutic use ; Middle Aged ; Rare Diseases/diagnosis ; Retreatment ; Retrospective Studies ; Young Adult

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Kruis, Wolfgang"" wg kryterium: Autor

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Język